Skip to main content
Top
Published in: Clinical Rheumatology 7/2014

01-07-2014 | Case Based Review

Rituximab for refractory digital infarcts and ulcers in systemic sclerosis

Authors: Chiew-Gek Khor, Xena Lung-Fang Chen, Ting-Syuan Lin, Cheng-Hsun Lu, Song-Chou Hsieh

Published in: Clinical Rheumatology | Issue 7/2014

Login to get access

Abstract

Systemic sclerosis is an uncommon connective tissue disease characterised by excessive deposition of collagen and vasculopathy which affects the skin and multiple internal organs. It is associated with autoimmunity, inflammation, vasculopathy and fibrosis. Managing Raynaud’s phenonemon, digital infarcts and ulcers in systemic sclerosis patients is often a challenge particularly among rheumatologists. We report a case of systemic sclerosis patient with refractory digital infarcts and ulcers responded successfully with rituximab.
Literature
1.
go back to reference Mouthon L, Mestre-Stanislas C, B´erezn´e A et al (2010) Impact of digital ulcers on disability and health-related quality of life in systemic sclerosis. Ann Rheum Dis 69(1):214–217PubMedCrossRef Mouthon L, Mestre-Stanislas C, B´erezn´e A et al (2010) Impact of digital ulcers on disability and health-related quality of life in systemic sclerosis. Ann Rheum Dis 69(1):214–217PubMedCrossRef
3.
go back to reference Generini S, Matucci Cerinic M (1999) Raynaud’s phenomenon and vascular disease in systemic sclerosis. Adv Exp Med Biol 455:93–100PubMedCrossRef Generini S, Matucci Cerinic M (1999) Raynaud’s phenomenon and vascular disease in systemic sclerosis. Adv Exp Med Biol 455:93–100PubMedCrossRef
4.
go back to reference Schiopu E, Impens Aj, Phillips K (2010) Digital ischemia in scleroderma spectrum of diseases. Int J Rheumatol 2010 pii:923743. Schiopu E, Impens Aj, Phillips K (2010) Digital ischemia in scleroderma spectrum of diseases. Int J Rheumatol 2010 pii:923743.
5.
go back to reference Fujimoto M, Sato S (2005) B lymphocytes and systemic sclerosis. Curr Opin Rheumatol 17(6):746–751PubMedCrossRef Fujimoto M, Sato S (2005) B lymphocytes and systemic sclerosis. Curr Opin Rheumatol 17(6):746–751PubMedCrossRef
7.
go back to reference Smith VP, Van Praet JT, Vandooren B et al (2010) Rituximab in diffuse cutaneous systemic sclerosis: an open-label clinical and histopathological study. Ann Rheum Dis 69(1):193–197PubMedCrossRef Smith VP, Van Praet JT, Vandooren B et al (2010) Rituximab in diffuse cutaneous systemic sclerosis: an open-label clinical and histopathological study. Ann Rheum Dis 69(1):193–197PubMedCrossRef
Metadata
Title
Rituximab for refractory digital infarcts and ulcers in systemic sclerosis
Authors
Chiew-Gek Khor
Xena Lung-Fang Chen
Ting-Syuan Lin
Cheng-Hsun Lu
Song-Chou Hsieh
Publication date
01-07-2014
Publisher
Springer London
Published in
Clinical Rheumatology / Issue 7/2014
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-014-2579-1

Other articles of this Issue 7/2014

Clinical Rheumatology 7/2014 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.